Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Beginning Balance at Dec. 31, 2021	$ 10	$ 641,406	$ (424,112)	$ (259)	$ 217,045
Beginning Balance (in shares) at Dec. 31, 2021	97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(9,285)		(9,285)
Other comprehensive (loss) income, net of tax				(2,515)	(2,515)
Stock-based compensation		5,854			5,854
Contingent consideration for acquisitions		530			530
Vesting of restricted stock awards (in shares)	245,855
Exercise of stock options		473			473
Exercise of stock options (in shares)	185,685
Income tax withholdings		(712)			(712)
Income tax withholdings (in shares)	(95,951)
Ending Balance at Mar. 31, 2022	$ 10	647,551	(433,397)	(2,774)	211,390
Ending Balance (in shares) at Mar. 31, 2022	98,297,186
Beginning Balance at Dec. 31, 2022	$ 10	670,537	(585,023)	(6,171)	79,353
Beginning Balance (in shares) at Dec. 31, 2022	98,206,323
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(38,740)		(38,740)
Other comprehensive (loss) income, net of tax				875	875
Stock-based compensation		6,894			6,894
Vesting of restricted stock awards (in shares)	295,414
Exercise of stock options		8			8
Exercise of stock options (in shares)	4,519
Income tax withholdings		(204)			(204)
Income tax withholdings (in shares)	(92,066)
Repurchases of common stock			(3,101)		(3,101)
Repurchases of common stock (in shares)	(1,396,158)
Proceeds from sale of common stock		191			191
Ending Balance at Mar. 31, 2023	$ 10	$ 677,426	$ (626,864)	$ (5,296)	$ 45,276
Ending Balance (in shares) at Mar. 31, 2023	97,018,032